Related Experiment Video
Updated: Jun 27, 2025

09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
Exosomal circ_0032704 confers sorafenib resistance to hepatocellular carcinoma and contributes to cancer malignant
Chengyun Dou1, Hongbo Zhu2, Xia Xie1
1Department of Infectious Diseases, the First Affiliated Hospital, Hengyang Medical School University of South China Hengyang Hunan China.
Annals of Gastroenterological Surgery
|May 6, 2024
Summary
Circular RNA circ_0032704 promotes sorafenib resistance in hepatocellular carcinoma (HCC) by targeting miR-514a-3p and upregulating PD-L1. Exosomal circ_0032704 also shows diagnostic potential for HCC.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Sorafenib is a first-line treatment for advanced HCC, but drug resistance remains a significant challenge.
- The role of circular RNAs (circRNAs) in HCC drug resistance is an emerging area of research.
Purpose of the Study:
- To investigate the function of circ_0032704 in the development of sorafenib resistance in HCC.
- To elucidate the underlying molecular mechanisms involving miR-514a-3p and programmed death-ligand 1 (PD-L1).
- To assess the potential of exosomal circ_0032704 as a diagnostic biomarker for HCC.
Main Methods:
- Quantitative real-time PCR (qPCR) and western blot were used to detect the expression of circ_0032704, miR-514a-3p, PD-L1, and related proteins.
- Cell viability, proliferation, migration, and invasion assays (CCK-8, EdU, wound healing, transwell) were performed.
- Dual-luciferase reporter, RIP, and pull-down assays confirmed the interaction between circ_0032704 and miR-514a-3p.
- Exosomes were isolated and characterized using transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA).
- In vivo efficacy was evaluated using xenograft models in mice.
Main Results:
- Circ_0032704 was significantly overexpressed in sorafenib-resistant HCC tissues and cells.
- Knockdown of circ_0032704 decreased sorafenib resistance, inhibited proliferation, migration, and invasion in HCC cells.
- Circ_0032704 positively regulated PD-L1 expression by sponging miR-514a-3p.
- Overexpression of PD-L1 reversed the inhibitory effects of circ_0032704 knockdown.
- Inhibition of circ_0032704 within exosomes reduced sorafenib resistance and tumor growth in vivo.
- Exosomal circ_0032704 demonstrated stability and diagnostic value.
Conclusions:
- Circ_0032704 plays a crucial role in enhancing sorafenib resistance and promoting malignant progression in HCC.
- Circ_0032704 can be transported via exosomes, and exosomal circ_0032704 holds promise as a diagnostic biomarker for HCC.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K

